| Primary |
| Cardiac Disorder |
25.9% |
| Varices Oesophageal |
14.8% |
| Gastritis |
11.1% |
| Gastrectomy |
7.4% |
| Sciatica |
7.4% |
| Abdominal Pain Upper |
3.7% |
| Ascites |
3.7% |
| Cardiovascular Disorder |
3.7% |
| Depression |
3.7% |
| Gastritis Prophylaxis |
3.7% |
| Hypertension |
3.7% |
| Hypovitaminosis |
3.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
3.7% |
| Vitamin Supplementation |
3.7% |
|
| Gastritis |
15.4% |
| Hypomagnesaemia |
15.4% |
| Anaemia |
7.7% |
| Dermatitis Bullous |
7.7% |
| Dermatitis Exfoliative Generalised |
7.7% |
| General Physical Health Deterioration |
7.7% |
| Hypotension |
7.7% |
| Rash Generalised |
7.7% |
| Rash Papular |
7.7% |
| Sopor |
7.7% |
| Vitreous Disorder |
7.7% |
|
| Secondary |
| Cardiac Disorder |
23.9% |
| Abdominal Pain Upper |
6.8% |
| Cardiovascular Disorder |
6.8% |
| Drug Use For Unknown Indication |
6.8% |
| Epilepsy |
6.8% |
| Hypertensive Cardiomyopathy |
6.8% |
| Parkinson's Disease |
6.8% |
| Endocarditis |
5.7% |
| Myocardial Infarction |
5.7% |
| Acute Myocardial Infarction |
4.5% |
| Gastritis |
4.5% |
| Gambling |
3.4% |
| Hyperthyroidism |
3.4% |
| Helicobacter Infection |
2.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.3% |
| Varices Oesophageal |
2.3% |
| Myelodysplastic Syndrome |
1.1% |
|
| Dermatitis Exfoliative Generalised |
22.7% |
| Skin Exfoliation |
13.6% |
| Pharyngeal Oedema |
9.1% |
| Aspartate Aminotransferase Increased |
4.5% |
| Asthenia |
4.5% |
| Colitis |
4.5% |
| Cough |
4.5% |
| Dermatitis Exfoliative |
4.5% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
4.5% |
| Epistaxis |
4.5% |
| Hepatitis |
4.5% |
| Periorbital Oedema |
4.5% |
| Pyrexia |
4.5% |
| Rash Erythematous |
4.5% |
| Stevens-johnson Syndrome |
4.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.4% |
| Hypertension |
13.5% |
| Drug Use For Unknown Indication |
6.9% |
| Cardiac Failure |
5.8% |
| Prophylaxis |
5.1% |
| Atrial Fibrillation |
4.1% |
| Myocardial Ischaemia |
3.9% |
| Diabetes Mellitus |
3.4% |
| Pain |
3.4% |
| Type 2 Diabetes Mellitus |
3.4% |
| Cardiomyopathy |
3.2% |
| Thrombosis Prophylaxis |
2.8% |
| B-cell Lymphoma |
2.7% |
| Gastric Cancer |
2.7% |
| Deep Vein Thrombosis |
1.9% |
| Diffuse Large B-cell Lymphoma |
1.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.9% |
| Gastritis |
1.4% |
| Rheumatoid Arthritis |
1.4% |
| Chemotherapy |
1.2% |
|
| Vomiting |
12.4% |
| Renal Failure Acute |
9.5% |
| Hyperkalaemia |
6.7% |
| Rhabdomyolysis |
6.7% |
| Thrombocytopenia |
6.7% |
| Syncope |
5.7% |
| Pancreatitis Acute |
4.8% |
| Rectal Haemorrhage |
4.8% |
| Torsade De Pointes |
4.8% |
| Melaena |
3.8% |
| Neutropenia |
3.8% |
| Nodal Arrhythmia |
3.8% |
| Ovarian Cancer |
3.8% |
| Polyarthritis |
3.8% |
| Respiratory Failure |
3.8% |
| Shock |
3.8% |
| Dyspnoea |
2.9% |
| Erythema |
2.9% |
| Febrile Neutropenia |
2.9% |
| Flushing |
2.9% |
|
